Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MDM2 | Q00987 | 1/20 | 0.42 |
| ▸ | SIRT2 | Q8IXJ6 | 11/20 | 0.41 |
| ▸ | SIRT1 | Q96EB6 | 9/20 | 0.40 |
| ▸ | TLR2 | O60603 | 1/20 | 0.40 |
| ▸ | TLR1 | Q15399 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | SIRT3 | Q9NTG7 | 3/20 | 0.39 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10143586 | 0.95 | MDM2 (0.42) | MDM2SIRT2SIRT1MEN1KMT2A | |
| SCHEMBL10143415 | 0.93 | CTSS (0.42) | MDM2SIRT2SIRT1TLR2TLR1 | |
| SCHEMBL10143408 | 0.93 | MDM2 (0.41) | MDM2SIRT2SIRT1TLR2TLR1 | |
| SCHEMBL10144158 | 0.90 | MDM2 (0.41) | MDM2SIRT2SIRT1TLR2TLR1 | |
| SCHEMBL10144445 | 0.90 | TLR2 (0.46) | MDM2SIRT2SIRT1TLR2SIRT3 | |
| SCHEMBL10143498 | 0.88 | MDM2 (0.41) | MDM2SIRT2SIRT1MEN1KMT2A | |
| SCHEMBL10144113 | 0.87 | MDM2 (0.41) | MDM2SIRT2SIRT1TLR2TLR1 | |
| SCHEMBL10144408 | 0.85 | TLR2 (0.47) | SIRT2SIRT1TLR2SIRT3 | |
| SCHEMBL10144449 | 0.83 | TLR2 (0.44) | MDM2TLR2 | |
| SCHEMBL10143568 | 0.83 | TLR2 (0.43) | MDM2TLR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012009258-A2 | PEPTIDOMIMETIC GALANIN RECEPTOR MODULATORS | ROBERTS EDWARD (US) | 2012-01-19 | — | — | WO | disclosed |